Industrial Transformation Training Centres - Grant ID: IC160100026
Funder
Australian Research Council
Funding Amount
$3,722,989.00
Summary
ARC Training Centre in Additive Biomanufacturing. ARC Training Centre in Additive Biomanufacturing. The training centre aims to bring together leading researchers and industry to develop and translate key technology platforms for personalised treatments of challenging medical conditions. The centre expects its research will lead to synergistic and innovative technologies needed for personalised therapies including: modular additive biomanufacturing platforms; advanced bio-inks for regenerative m ....ARC Training Centre in Additive Biomanufacturing. ARC Training Centre in Additive Biomanufacturing. The training centre aims to bring together leading researchers and industry to develop and translate key technology platforms for personalised treatments of challenging medical conditions. The centre expects its research will lead to synergistic and innovative technologies needed for personalised therapies including: modular additive biomanufacturing platforms; advanced bio-inks for regenerative medicine; and additive manufactured tools for surgical planning and education. Highly experienced researchers and industry partners with teams of exceptional post-doctoral fellows and doctoral students would drive each technology. Anticipated impacts are that Australia will be a world-leader in additive biomanufacturing, and that the research will change the fields of science, health and biotechnology.Read moreRead less
Linkage Infrastructure, Equipment And Facilities - Grant ID: LE180100175
Funder
Australian Research Council
Funding Amount
$347,070.00
Summary
Three-dimensional additive bio-fabrication facility: printing bioprinters. This project aims to develop bioprinting systems that will provide new insights into fundamental biological processes. The 3D Additive Bio-Fabrication Facility - Printing Bioprinters capability will use 3D polymer and metal additive manufacturing technologies to create the next generation of bioprinting methodologies and 3D fabrication tools. It is the aim that these customised additive manufacturing systems will be used ....Three-dimensional additive bio-fabrication facility: printing bioprinters. This project aims to develop bioprinting systems that will provide new insights into fundamental biological processes. The 3D Additive Bio-Fabrication Facility - Printing Bioprinters capability will use 3D polymer and metal additive manufacturing technologies to create the next generation of bioprinting methodologies and 3D fabrication tools. It is the aim that these customised additive manufacturing systems will be used to produce structures wherein living cells are spatially organised in combination with appropriate biomaterials and bioactive components, such as drugs or growth factors, in order to influence subsequent biological behaviour.Read moreRead less
Scaling manufacture of three-dimensional microstructures for the medical devices industry. Scaling manufacture of three-dimensional microstructures for the medical devices industry. This project aims to transform microscale three-dimensional prototyping into a cheap high volume manufacturing process through a novel soft embossing process. Although three-dimensional printing has been hailed as a disruptive technology, because it can print complex shapes directly from drawings, it is too slow at m ....Scaling manufacture of three-dimensional microstructures for the medical devices industry. Scaling manufacture of three-dimensional microstructures for the medical devices industry. This project aims to transform microscale three-dimensional prototyping into a cheap high volume manufacturing process through a novel soft embossing process. Although three-dimensional printing has been hailed as a disruptive technology, because it can print complex shapes directly from drawings, it is too slow at microscale for high volume manufacture. This research will develop microdevices for painless collection of blood, its analysis, and drug delivery. Cost-effective manufacture of these microdevices is expected to tap into the large medical devices industry, leading to establishing new businesses in the point-of-care and drug delivery markets.Read moreRead less